Publications by authors named "Greg Rossi"

Claim this Profile
P
Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy-induced anemia.
Jeffrey Blumer, Stacey Berg, Peter C Adamson, Thomas Loew, Greg Rossi

Pediatr Blood Cancer· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks.
Janice L Gabrilove, Edith A Perez, Dianne K Tomita, Greg Rossi, Charles S Cleeland

Cancer· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced anemia.
Veena Charu, Bruce Saidman, Ali Ben-Jacob, Glen R Justice, Ajit S Maniam, Greg Rossi

Oncologist· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled trial comparing darbepoetin alfa correction/maintenance dosing with weekly dosing for treating chemotherapy-induced anemia.
Dusan Kotasek, Jean-Luc Canon, Maria Victoria Mateos, Michael Hedenus, Greg Rossi

Curr Med Res Opin· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: a controlled, randomized, open-label phase II trial.
Veena Charu, Chandra P Belani, Ahmad N Gill, Mukesh Bhatt, Dianne Tomita, Greg Rossi

Oncologist· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of darbepoetin alfa after intravenous or subcutaneous administration in patients with non-myeloid malignancies undergoing chemotherapy.
Anne C Heatherington, Christian Dittrich, John T Sullivan, Greg Rossi, Johannes Schueller

Clin Pharmacokinet· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial.

J Clin Oncol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia.
Jean-Luc Canon, Johan Vansteenkiste, György Bodoky, M Victoria Mateos, Laurent Bastit, Greg Rossi

J Natl Cancer Inst· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective cohort study to assess the impact of therapeutic substitution of darbepoetin alfa for epoetin alfa in anemic patients with myelodysplastic syndrome.
Jeffrey F Patton, Toni Sullivan, Yong Mun, Timothy Reeves, Greg Rossi

J Support Oncol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chemotherapy-induced anemia in breast cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40,000 U weekly.
Frank M Senecal, Lorrin Yee, Nashat Gabrail, Veena Charu, Dianne Tomita, Greg Rossi

Clin Breast Cancer· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: a randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa.
John Glaspy, David Henry, Ravi Patel, Simon Tchekmedyian, Steve Applebaum, Greg Rossi

Eur J Cancer· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer.
Lee S Schwartzberg, Lorrin K Yee, Frank M Senecal, Veena Charu, Dianne Tomita, Greg Rossi

Oncologist· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia.
Lee Schwartzberg, Roger Shiffman, Dianne Tomita, Bradley Stolshek, Greg Rossi

Clin Ther· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis